BBP vs. UTES
BBP (Virtus LifeSci Biotech Products ETF) and UTES (Virtus Reaves Utilities ETF) are both exchange-traded funds - BBP is a Health & Biotech Equities fund tracking the LifeSci Biotechnology Products Index, while UTES is a Utilities Equities fund actively managed by Virtus Investment Partners. BBP is passively managed, while UTES is actively managed. Over the past 10 years, BBP returned 11.61%/yr vs 12.40%/yr for UTES. At a 0.19 correlation, their price movements are largely independent. BBP charges 0.79%/yr vs 0.49%/yr for UTES.
Performance
BBP vs. UTES - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, BBP achieves a 5.80% return, which is significantly higher than UTES's 0.08% return. Over the past 10 years, BBP has underperformed UTES with an annualized return of 11.61%, while UTES has yielded a comparatively higher 12.40% annualized return.
BBP
- 1D
- 1.18%
- 1M
- -3.14%
- YTD
- 5.80%
- 6M
- 7.91%
- 1Y
- 45.02%
- 3Y*
- 16.70%
- 5Y*
- 10.37%
- 10Y*
- 11.61%
UTES
- 1D
- -0.98%
- 1M
- -6.58%
- YTD
- 0.08%
- 6M
- -1.81%
- 1Y
- 7.86%
- 3Y*
- 22.78%
- 5Y*
- 15.66%
- 10Y*
- 12.40%
BBP vs. UTES - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
BBP Virtus LifeSci Biotech Products ETF | 5.80% | 33.15% | 3.32% | 17.88% | 0.85% | -8.17% | 22.24% | 24.73% | -13.95% | 24.07% |
UTES Virtus Reaves Utilities ETF | 0.08% | 25.71% | 45.35% | -2.46% | 0.80% | 20.74% | -0.30% | 25.48% | 5.14% | 14.21% |
Correlation
The correlation between BBP and UTES is 0.16, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.16 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.28 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.27 |
Correlation (10Y) Calculated over the trailing 10-year period | 0.21 |
Correlation (All Time) Calculated using the full available price history since Sep 25, 2015 | 0.19 |
The correlation between BBP and UTES shifts across timeframes, from 0.16 (1 year) to 0.28 (3 years), reflecting how their relationship changes across market environments.
BBP vs. UTES - Sectors Allocation Comparison
Sectors
BBP
UTES
Healthcare
-
Basic Materials
-
-
Communication Services
-
-
Consumer Cyclical
-
-
Consumer Defensive
-
-
Energy
-
-
Financial Services
-
-
Industrials
-
-
Real Estate
-
-
Technology
-
-
Utilities
-
Healthcare
BBP
UTES
-
Basic Materials
BBP
-
UTES
-
Communication Services
BBP
-
UTES
-
Consumer Cyclical
BBP
-
UTES
-
Consumer Defensive
BBP
-
UTES
-
Energy
BBP
-
UTES
-
Financial Services
BBP
-
UTES
-
Industrials
BBP
-
UTES
-
Real Estate
BBP
-
UTES
-
Technology
BBP
-
UTES
-
Utilities
BBP
-
UTES
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
BBP vs. UTES — Risk / Return Rank
BBP
UTES
BBP vs. UTES - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Virtus LifeSci Biotech Products ETF (BBP) and Virtus Reaves Utilities ETF (UTES). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| BBP | UTES | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +1.54 | ||
| Sortino ratioReturn per unit of downside risk | +2.09 | ||
| Omega ratioGain probability vs. loss probability | 1.32 | 1.08 | +0.24 |
| Calmar ratioReturn relative to maximum drawdown | 4.87 | 0.57 | +4.31 |
| Martin ratioReturn relative to average drawdown | 15.32 | 1.30 | +14.02 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading charts...
Sharpe Ratios by Period
| BBP | UTES | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 1.91 | 0.37 | +1.54 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | 0.40 | 0.76 | -0.37 |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | 0.42 | 0.62 | -0.19 |
Sharpe Ratio (All Time)Calculated using the full available price history | 0.39 | 0.70 | -0.30 |
Drawdowns
BBP vs. UTES - Drawdown Comparison
The maximum BBP drawdown since its inception was -44.32%, which is greater than UTES's maximum drawdown of -35.39%. Use the drawdown chart below to compare losses from any high point for BBP and UTES.
Loading charts...
Drawdown Indicators
| BBP | UTES | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -44.32% | -35.39% | -8.93% |
Max Drawdown (1Y)Largest decline over 1 year | -9.28% | -13.88% | +4.60% |
Max Drawdown (3Y)Largest decline over 3 years | -26.09% | -17.62% | -8.47% |
Max Drawdown (5Y)Largest decline over 5 years | -38.28% | -20.40% | -17.88% |
Max Drawdown (10Y)Largest decline over 10 years | -44.32% | -35.39% | -8.93% |
Current DrawdownCurrent decline from peak | -6.47% | -9.26% | +2.79% |
Average DrawdownAverage peak-to-trough decline | -12.02% | -5.52% | -6.50% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 2.95% | 6.08% | -3.13% |
Volatility
BBP vs. UTES - Volatility Comparison
Virtus LifeSci Biotech Products ETF (BBP) and Virtus Reaves Utilities ETF (UTES) have volatilities of 7.61% and 7.40%, respectively, indicating that both stocks experience similar levels of price fluctuations. This suggests that the risk associated with both stocks, as measured by volatility, is nearly the same. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| BBP | UTES | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 7.61% | 7.40% | +0.21% |
Volatility (6M)Calculated over the trailing 6-month period | 18.43% | 16.95% | +1.48% |
Volatility (1Y)Calculated over the trailing 1-year period | 23.76% | 21.27% | +2.49% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 26.35% | 20.60% | +5.75% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 27.40% | 20.16% | +7.24% |
BBP vs. UTES - Expense Ratio Comparison
BBP has a 0.79% expense ratio, which is higher than UTES's 0.49% expense ratio.
Dividends
BBP vs. UTES - Dividend Comparison
BBP has not paid dividends to shareholders, while UTES's dividend yield for the trailing twelve months is around 1.50%.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
BBP Virtus LifeSci Biotech Products ETF | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.18% | 0.00% | 1.29% |
UTES Virtus Reaves Utilities ETF | 1.50% | 1.42% | 1.51% | 2.44% | 2.13% | 1.94% | 2.09% | 1.84% | 2.09% | 3.44% | 3.53% | 0.61% |
Frequently Asked Questions
BBP and UTES have a correlation of 0.16, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
BBP has higher volatility (7.61%) compared to UTES (7.40%). In terms of maximum drawdown, BBP dropped -44.32% vs UTES's -35.39%.
On 10-year performance, UTES leads with 12.40% vs 11.61% for BBP. On fees, UTES is cheaper at 0.49% per year. On volatility, UTES has been the lower-risk option at 7.40%. The better choice depends on whether you care most about return, fees, risk, or income.
Over the 10-year period, UTES has performed better with a 12.40% return vs 11.61%. Past performance does not guarantee future results, so compare this with risk, fees, and fund exposure.
UTES is cheaper with a 0.49% expense ratio, compared with 0.79% for BBP.
UTES has the higher dividend yield at 1.50%, compared with 0.00% for BBP.
BBP is categorized as Health & Biotech Equities, while UTES is Utilities Equities. Their fees differ too: 0.79% for BBP and 0.49% for UTES.
BBP currently has the higher Sharpe Ratio (1.91 vs 0.37), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for BBP and UTES
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer